Merit Medical Systems, Inc. Announces FDA Completes Evaluation
Published: Oct 24, 2012
SOUTH JORDAN, Utah, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that the U.S. Food and Drug Administration (FDA) has completed its evaluation of Merit's corrective actions in response to a Warning Letter issued to the Company dated January 30, 2012 related to the Merit Laureate® Hydrophilic Guidewire. The FDA sent a letter to Merit Medical this week stating that it appears Merit has addressed the violation contained in the Warning Letter.